thiophenes has been researched along with Cancer of Cervix in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, Y; Fujiwara, T; Hanaoka, H; Hanawa, M; Hasegawa, S; Hattori, Y; Hori, M; Kawasaki, Y; Kurokawa, T; Murata, K; Okonogi, N; Shozu, M; Suzuki, K; Tsuji, H; Tsuyuki, K; Usui, H; Wakatsuki, M; Yamada, S | 1 |
| Bhattacharyya, S; De, R; Kaur, H; Pal, A; Sharma, A; Srinivasan, R | 1 |
| Itoh, H; Kanayama, N; Matsuya-Ogawa, M; Murakami, H; Shibata, T; Sugihara, K; Yaguchi, C | 1 |
| Bao, J; He, F; Liu, KS; Nong, XH; Qi, SH; Sun, YL; Wang, YF; Zhang, XY | 1 |
| Cao, W; Du, B; Li, Y; Ren, X; Wei, Q; Zhang, X | 1 |
| Li, XY; Liu, L; Xie, XM; Zhou, C | 1 |
| Shin, SB; Woo, SU; Yim, H | 1 |
| Li, YH; Tan, W; Tan, ZH; Tian, Y; Zhang, Y | 1 |
| Balzarini, J; Baraldi, PG; Brancale, A; Cruz-Lopez, O; Di Cristina, A; Grimaudo, S; Hamel, E; Pipitone, RM; Romagnoli, R; Tolomeo, M | 1 |
| Agarwal, K; Gupta, A; Gupta, P; Satija, S; Tomar, P | 1 |
| Aherne, GW; Hardcastle, A; Jackman, AL; Kelland, LR; Kimbell, R | 1 |
1 trial(s) available for thiophenes and Cancer of Cervix
| Article | Year |
|---|---|
Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carbon; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase I as Topic; Female; Humans; Imidazoles; Neoplasm Staging; Prospective Studies; Sulfonamides; Thiophenes; Uterine Cervical Neoplasms | 2022 |
10 other study(ies) available for thiophenes and Cancer of Cervix
| Article | Year |
|---|---|
Knockdown of E-cadherin induces cancer stem-cell-like phenotype and drug resistance in cervical cancer cells.
Topics: Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Female; Humans; Neoplastic Stem Cells; Phenotype; Pyridines; RNA, Small Interfering; Thiophenes; Uterine Cervical Neoplasms; Veratrum Alkaloids | 2021 |
Oncoprotective Effects of Short-Chain Fatty Acids on Uterine Cervical Neoplasia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Butyrates; Cell Proliferation; Fatty Acids, Volatile; Female; HeLa Cells; Humans; Immunohistochemistry; Middle Aged; Neoplasm Grading; Receptors, Cell Surface; Thiophenes; Uterine Cervical Neoplasms | 2019 |
Cytotoxic dihydrothiophene-condensed chromones from the marine-derived fungus Penicillium oxalicum.
Topics: Antineoplastic Agents; Biological Products; Chromones; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Penicillium; Structure-Activity Relationship; Thiophenes; Uterine Cervical Neoplasms | 2013 |
Simultaneous electrochemical immunosensor based on water-soluble polythiophene derivative and functionalized magnetic material.
Topics: Antigens, Neoplasm; Biosensing Techniques; Electrochemical Techniques; Female; Humans; Immunoassay; Magnetite Nanoparticles; Polymers; Porosity; Solubility; Surface Properties; Thiophenes; Uterine Cervical Neoplasms; Water | 2014 |
The role of raltitrexed/cisplatin with concurrent radiation therapy in treating advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Middle Aged; Quinazolines; Survival Rate; Thiophenes; Treatment Outcome; Uterine Cervical Neoplasms | 2014 |
Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzimidazoles; Benzoates; Benzoquinones; Binding Sites; Catalytic Domain; Cell Cycle Proteins; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Design; Female; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Inhibitory Concentration 50; Mitosis; Molecular Targeted Therapy; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Pteridines; Quinones; S Phase Cell Cycle Checkpoints; Signal Transduction; Thiophenes; Time Factors; Uterine Cervical Neoplasms | 2015 |
IκB kinase b Mediating the Downregulation of p53 and p21 by Lipopolysaccharide in Human Papillomavirus 16
Topics: Cell Line, Tumor; Down-Regulation; Female; Human papillomavirus 16; Humans; I-kappa B Kinase; Lipopolysaccharides; Proto-Oncogene Proteins p21(ras); Thiophenes; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2016 |
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivatives.
Topics: Animals; Antimitotic Agents; Cell Line, Tumor; Cell Proliferation; Female; Humans; Leukemia; Mice; Molecular Structure; Structure-Activity Relationship; Thiophenes; Uterine Cervical Neoplasms | 2011 |
Antioxidant and cytotoxic potential of a new thienyl derivative from Tagetes erecta roots.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Cell Line, Tumor; Cell Survival; Drug Discovery; Ethnopharmacology; Female; Free Radical Scavengers; HeLa Cells; Humans; India; Inhibitory Concentration 50; Male; Molecular Structure; Plant Extracts; Plant Roots; Prostatic Neoplasms; Tagetes; Thiophenes; Uterine Cervical Neoplasms | 2012 |
Relationships between resistance to cisplatin and antifolates in sensitive and resistant tumour cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance; Female; Folic Acid; Folic Acid Antagonists; Humans; Male; Ovarian Neoplasms; Quinazolines; Testicular Neoplasms; Thiophenes; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1995 |